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objective: Patients who underwent heart transplantation (HTX) experience a reduction in the elevation that is usual in systolic 
blood pressure during exercise testing. Of unknown origin, this phenomenon varies in frequency and intensity. The aim of 
this study was to analyze the relationship between systolic blood pressure increase (delta SBP) and clinical aspects, as well as 
variables measured during exercise testing (ET) and dobutamine stress echocardiography (DSE) in patients in the late post-
transplantation course.
Methods: Forty-five men, mean age 49.04 ± 10.19, underwent clinical assessment, ET and DSE 40.91 ± 27.46 months after 
heart transplantation. Left ventricular wall motion score index and ejection fraction were assessed. Delta SBP < 35mmHg 
during ET was considered abnormal (SBC,1995).
Results: No significant correlation was found between delta SBP and post-transplantation time, graft ischemic time, history 
of rejection, diltiazem dosage, oxygen uptake, ejection fraction, and wall motion score index (WMSI). Delta SBP was normal 
in 17 patients (Group I) and abnormal in 28 (Group II). Patients of both groups did not differ significantly in regard to clinical 
features and ET and DSE results.
Conclusion: Unlike other populations, no correlation was found between delta SBP during exercise testing and clinical 
condition or left ventricular function in heart transplant patients. Pathophysiological factors associated with delta SBP reduction 
during exercise testing remain unknown.
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Systolic blood pressure elevation (delta SBP) during 
exercise testing (ET) has been related to left ventricular (LV) 
performance1. In LV contractile dysfunction cases caused by 
ischemia or LV outflow tract obstruction, lower delta SBP 
values have been described1. In the early and late post-
transplantation (HTX) course, a depressed response in SBP2-6 
and mean BP7-9 during ET has been observed. In an analysis of 
consecutive ET performed after heart transplantation showed 
that 69% of the heart recipients showed a depressed response 
of SBP during exercise testing10; delta SBP < 35mmHg 
was considered abnormal (SBC,1995)11. The cause of SBP 
depressed response during ET after heart transplantation is 
still unclear7. It may be associated with graft vascular disease, 
one of the frequent causes of mortality among heart recipient 
survivors12.
The aim of this study was to determine indicators of 
attenuated behavior of SBP during ET in male patients who 
underwent heart transplantation using clinical variables and 
parameters derived from ET and DSE.
Methods
Forty-five men, mean age 49.04 ± 10.19, were studied 
40.91 ± 27.46 months after heart transplantation. Causes for 
transplantation were: idiopathic dilated cardiomyopathy (40%), 
chronic Chagas cardiomyopathy (33%), chronic ischemic 
cardiomyopathy (25%), and hypertensive cardiomyopathy (2%). 
Study patients were in NYHA functional class I (n = 43) and 
II (n = 2) and using cyclosporine A, azathioprine, prednisone, 
anti-hypertensive, lipid-lowering, and hypoglycemic drugs 
regularly. No patient showed rejection episodes exceeding 
grade 3A (International Society Heart Lung Transplantation) 
for at least two months. Mean graft ischemic time was 114.24 
± 29.73 minutes.
Symptom-limited exercise treadmill tests (TRACKMASTER 
TM 500-E) were conducted according to the Bruce protocol 
with a 13-lead ECG recording (TEB-APEX 2000). Systolic blood 
pressure (SBP) was measured at phase I of Korotkoff sounds 
and diastolic blood pressure (DBP) was measured at phase V, 
using a mercury sphygmomanometer. Oxygen uptake (VO2) 
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predicted HRmax, VO2 max, FAI, endurance time (p = NS). 
Exercise testing was considered ischemic in two patients from 
group I and one patient from group II. SBP values at exercise 
peak and delta SBP were significantly lower in group II (p < 
0.001).
DSE results are presented in Tables 5 and 6. Both groups 
underwent stress with the same dose of dobutamine and 
reached equivalent percentages of predicted HRmax. One 
patient from group I and four patients from group II required 
atropine co-administration.
There were no significant differences between groups with 
respect to: [1] WMSI and EF values at rest and at peak infusion; 
[2] abnormal WMSI at rest and at peak infusion; [3] presence 
of myocardial ischemia.
Discussion
Blood pressure is governed by a complex mechanism 
involving hemodynamic, neural, and hormonal factors. Its 
determinants are cardiac output and peripheral resistance. 
SBP is primarily related to factors influencing ventricular 
performance, namely contractility, the degree to which 
myocardial fibers are stretched (Frank-Starling principle), 
blood volume, resistance to blood ejection  (afterload), and 
heart rate.
The SBP rises during exercise, showing a 50% increase over 
its baseline value at maximal exercise16. In this study, 62% of 
the patients experienced a depressed response in SBP during 
ET performed at late post-transplantation course. It has been 
suggested that abnormal delta SPB during ET is associated with 
reduced inotropic reserve secondary to changes in contractility 
caused by coronary disease, Chagas cardiomyopathy, 
hypertensive cardiomyopathy, dilated cardiomyopathy, and 
other heart diseases1,17-19.
Our results showed no correlation between abnormal delta 
SBP and post-transplantation time. On average, patients had 
undergone heart transplantation more than three years earlier 
was estimated by regression equation13. Functional Aerobic 
Impairment (FAI) was defined by the following formula: FAI = 
(predicted VO2 max – measured VO2max) / predicted VO2 max 
x 102. FAI values between – 27% to + 26% were considered 
normal1. Exercise test results were analyzed according to 
criteria established by the Brazilian Society of Cardiology11.
During dobutamine stress echocardiography (Ultramark 
9-HDI, ATL), intravenous dobutamine was infused with or 
without atropine14. Regional LV contractility was evaluated 
by using the 16-segment model15, and the mean score was 
considered as the wall motion score index (WMSI)15. Left 
ventricular ejection fraction (EF) was determined by Simpson’s 
method, both at rest and at peak infusion (Image VueTM 
DCRTM, Nova Microsonics). Resting EF values above 0.55 
were regarded as normal15. No reference values for EF at peak 
dobutamine infusion are reported in the literature
All procedures (clinical evaluation, ET, and DSE) were 
performed by independent observers.
The correlation between delta SBP and the following 
variables were analyzed: post-transplantation time, graft 
ischemic time, diltiazem dosage, VO2max, resting EF, peak 
EF, delta EF, and % delta EF. Subsequently, patients were 
distributed into two groups: Group I - normal delta SBP 
(n = 17) and Group II - abnormal delta SBP (n = 28), so 
that possible markers of attenuated SBP responses between 
clinical variables and parameters measured by ET and DSE 
could be studied.
Pearson’s correlation coefficient and multiple linear 
regressions were used to evaluate the linear relationship 
between delta SBP and selected variables. The Student’s 
t-test, Fisher’s exact test, and Pearson’s chi-square test with 
Yates’ correction were used to compare groups I and II. The 
paired t test and McNemar’s test were applied to compare 
resting and peak values. P values < 0.05 were considered 
statistically significant.
The protocol was approved by the Institutional Research 
Ethics Committee, and all patients signed an informed consent 
before entering the study.
Results
No significant linear correlation was found between delta 
SBP and post-transplantation time, graft ischemic time, 
diltiazem dosage, VO2max, resting EF, peak EF, and EF variation 
in absolute and relative values (Tab. 1).
The combined analysis of 10 variables, for which multiple 
linear regression (resting EF, peak EF, and % EF, WMSI at 
rest, WMSI at peak infusion, post-transplantation time, graft 
ischemic time, history of rejection episodes ≥ 3 A, diltiazem 
dosage, VO2max) were used, showed that no variable, at the 
10% significance level,  influenced delta SBP values (Tab. 2).
No significant differences were found between groups I 
and II regarding age, body weight, height, post-transplantation 
time, graft ischemic time, arterial hypertension, dyslipidemia 
and obesity, history of rejection ≥ 3 A, and use of prednisone, 
statins or diltiazem (Tab. 3).
Exercise test results are described in Table 4.Groups I and 
II showed similar resting heart rate (HR), resting BP, % of 
variable r p
Post-transplantation time -0.155 0.309
Graft ischemic time 0.080 0.638
Diltiazem dosage 0.114 0.561
VO2max 0.003 0.980
Resting EF -0.075 0.620
Peak EF -0.245 0.103
ΔEF -0.160 0.293
(%) ΔEF -0.142 0.356
r - Pearson’s correlation coefficient; VO2 - oxygen uptake; EF - ejection 
fraction.
ΔFE =  EF at peak dobutamine – resting EF.
ΔEF (%) =   Peak EF – Resting EF x 100
                         Resting EF
table 1 - Correlation between Sbp increase during exercise test 
and other variables in heart transplant recipients (n = 45)
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and, thereby, were subject to graft vascular disease.
Graft vascular disease is the major cause of death after 
the first year of heart transplantation20. Dobutamine stress 
echocardiography has emerged as a promising non-invasive 
examination for detecting this condition21, with sensitivity of 
67% to 100%, specificity of 55% to 89.5%, negative predictive 
value of 90% to 100% and positive predictive value of 33% 
to 76%22-25. Graft vascular disease may cause changes in LV 
contractility, affecting delta SBP. The association between delta 
SBP and ischemia secondary to graft vascular disease is yet 
to be established. Myocardial ischemia incidence in groups 
I and II by DSE was 6% and 21%, respectively; however, no 
statistical significance was found between these values (p = 
0.227), even though ischemia was three times higher in group 
II. This lack of significance may be related to the number of 
patients studied. Nor was significant difference found between 
groups I and II regarding, respectively, EF decrease at peak 
DSE (35.3% vs 17.8%) and mean EF increase during DSE (6.06 
± 16.03 vs 13.83 ± 17.74).
Rejection episodes are common after heart transplantation 
and, if repeated, may cause fibrosis and a decrease in 
ventricular cavity size9. Under dobutamine stress, Bellotti et 
al. reported normal contractility in heart transplant recipients 
in whom there was no rejection. In the presence of rejection, 
contractility was reduced26. Our series did not corroborate 
these findings, since history of rejection was similar in groups 
I and II (23% vs 18%, p = NS). Among the nine patients with 
variable Coefficient Standard error p
Post-transplantation 
time -0.008 0.641 0.990
Graft ischemic time 0.023 0.296 0.941
History of rejection 
> 3 A (ISHLT) 4.349 15.037 0.779
Diltiazem dosage 0.030 0.129 0.821
VO2 max 0.686 1.521 0.663
Resting EF -3.671 4.100 0.394
Peak EF 1.912 3.418 0.590
ΔEF (%) -1,365 1,886 0,488
Resting WMSI 11.557 35.385 0.751
Peak WMSI -17.573 28.585 0.554
VO2 – oxygen uptake; FE – ejection fraction; WMSI -  wall motion score 
index
ΔEF (%) =   Peak EF – Resting EF x 100
                         Resting EF
table 2 - Multiple linear regression results for Sbp increase during 
exercise test in heart transplant recipients (n = 45)
variable group i(n = 17)
group ii
(n = 28) p
Age (years) 48.65 ± 11.58 49.29 ± 9.46 0.84
Body weight 
(kg) 74.71 ± 11.25 70.86 ± 9.50 0.23
Height (cm) 168.88 ± 4.47 167.29 ± 5.42 0.31
Post-
transplantation 
time (months)
32.88 ± 15.52 45.78 ± 31.95 0.13
Graft time 
(min) 115.26 ± 22.90 113.55 ± 34.12 0.87
Arterial 
hypertension 15 (88%) 24 (86%) > 0.99
Dyslipidemia 7 (41%) 14 (50%) 0.56
Obesity 5 (29%) 2 (7%) 0.09
History of 
rejection > 3 
A (ISHLT)
4 (23%) 5 (18%) 0.94
Use of 
prednisone 6 (35%) 8 (29%) 0.64
Use of statins 4 (23%) 11 (39%) 0.28
Diltiazem 
dosage (mg) 165 ± 58.74 160 ± 46.02 0.80
Post-transplantation time - time elapsed since transplantation; Graft 
time  - graft ischemic time.
table 3 - Clinical data of heart transplant recipients (n = 45)
variable group i(n = 17)
group ii
(n = 28) p
VO2max 
(mL/kg/min) 29.70 ± 6.20 28.94 ± 4.71 0.642
FAI (%) 18.27 ± 24.91 19.82 ± 13.24 0.787
Endurance 
time (min) 8.20 ± 2.46 8.21 ± 1.96 0.988
Resting HR 
(bpm) 101.06 ± 9.32 94.68 ± 10.97 0.052
Peak HR 
(bpm) 163.29 ± 21.29 154.96 ± 14.91 0.130
% HRmax. 95.29 ± 11.46 90.54 ± 7.42 0.097
Resting SBP 
(mmHg) 128.82 ± 17.72 134.64 ± 19.19 0.316
Peak SBP 
(mmHg) 176.47 ± 17.30 154.11 ± 19.72
< 
0.001
ΔSBP 
(mmHg) 47.64 ± 8.12 19.46 ± 8.53
< 
0.001
Resting SBP 
(mmHg) 89.71 ± 12.05 91.96 ± 9.75 0.495
Peak SBP 
(mmHg) 90.88 ± 13.26 85.36 ± 12.17 0.160
VO2 – oxygen uptake; FAI - functional aerobic impairment; HR – heart 
rate; SBP – systolic blood pressure; DBP – diastolic blood pressure; ΔSBP 
= peak SBP – resting SBP.
table 4 - variables of exercise test in heart transplant  
recipients (n = 45)
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history of rejection, only three showed changes in contractility, 
two from Group I (normal delta SBP) and one from Group 
II (abnormal delta SBP). No case of ventricular fibrosis or 
reduction in ventricular cavity was identified.
Some authors have attributed the enhanced pressure 
response to exercise to a late sympathetic reinnervation. 
Wilson et al described  a trend to increased delta SBP 
during late follow-up of patients with evidence of marked 
reinnervation after heart transplantation27.
Abnormal delta SBP values might be influenced by LV 
stiffness and dysfunction secondary to ventricular ischemia 
caused during cold preservation of the graft28,29. In our series, 
mean graft ischemic time was 114 minutes and was not 
correlated with abnormal  delta SBP. According to Kao et al, 
it is unlikely that two hours of cold ischemia would cause 
changes in the graft capable of persisting up to 16 months 
post-transplantation8.
Diltiazem hydrochloride has been frequently used for BP 
control after heart transplantation. In our series, 28 (62.2%) 
patients took diltiazem regularly at doses ranging from 60 to 
240 mg/day. Drug dosage did not correlate with delta SBP 
during exercise testing. Both the percentage of patients on 
diltiazem and the dose used were similar in both groups.
No correlation was found between abnormal delta SBP 
and VO2max. According to the Fick principle, VO2 varies with 
HR, stroke volume, and arteriovenous oxygen difference. SBP 
Arq Bras Cardiol 2006; 87 : 574-578
is a function of HR, stroke volume, contractility, preload and 
afterload. Therefore, it would be possible to detect abnormal 
delta SBP in the presence of the decreased VO2max values. 
Douard et al30 found a significant correlation between SBP 
peak values and VO2max. In our study, not only was this 
relationship not observed, but groups I and II reached equal 
VO2max values. These results may have been affected by the 
estimated values used, calculated from formulas that were 
perhaps inadequate for transplant patients. Actually, the use 
of direct measurements of VO2max in cardiopulmonary tests 
would have been more appropriate.
Overall, LV systolic performance after heart transplantation 
has been shown to be satisfactory at rest and during exercise. 
Most studies have reported normal LV values at rest and at 
exercise peak, during both early and late follow-up8,9,31-37. In 
our study, LV systolic function, assessed by the WMSI and EF, 
showed no correlation with abnormal delta SBP. WMSI and 
EF values were similar in patients of both  groups. Our results 
were corroborated by other authors. Pflugfelder at al found 
no correlation between peak EF and peak BP during exercise 
in patients after thirteen months of transplantation32.
Other clinical, ergometric, and echocardiographic 
measurements also failed to characterize the abnormal delta 
SBP group. Groups I and II shared the same clinical features, 
and their results were similar on ET and DSE.
Limitations - Our study has some limitations, [1] namely, the 
small number of patients in groups I and II; [2] and population 
heterogeneity regarding different etiologies.
variable group i(n = 17)
group ii
(n = 28) p
Resting EF 0.65 ± 0.09 0.64 ± 0.09 0.877
Peak EF 0.68 ± 0.09 0.72 ± 0.09 0.147
ΔEF 0.03 ± 0.10 0.08 ± 0.09 0.126
ΔEF (%) 6.06 ± 16.03 13.83 ± 17.74 0.150
Resting 
WMSI 1.06 ± 0.24 1.13 ± 0.36 0.865
Peak WMSI 1.10 ± 0.40 1.14 ± 0.30 0.297
% HRmax. 93.53 ± 8.12 91.18 ± 7.12 0.314
Resting SBP 
(mmHg) 125.29 ± 16.99 135.89 ± 17.59 0.054
Peak SBP 
(mmHg) 132.35 ± 19.53 132.14 ± 17.50 0.970
ΔSBP 
(mmHg) 7.06 ± 22.85 -3.75 ± 24.37 0.147
Dobutamine 
(µg/kg/min) 30.00 ± 8.66 30.36 ± 8.38 0.892
FE– ejection fraction; WMSI– wall motion score index; HR– heart rate; 
SBP– systolic blood pressure. 
ΔEF = EF at peak  dobutamine – resting EF
ΔFE (%) = FE pico – FE repouso x 100
                              FE repouso
ΔSBP = peak SBP – resting SBP
table 5 - dobutamine stress echocardiogram variables in heart 
transplant recipients (n = 45)
variable group i(n = 17)
group ii
(n = 28) p
WMSI (resting) 1 (6.0%) 5 (17.8%) 0.385
WMSI (peak) 1 (6.0%) 7 (25.0%) 0.132
Myocardial 
ischemia 1 (6.0%) 6 (21.0%) 0.227
EF reduction 
(peak) 6 (35.3%) 5 (17.8%) 0.284
WMSI- wall motion score index; EF- ejection fraction.
table 6 - Changes in dobutamine stress echocardiogram in heart 
transplant recipients (n = 45)
Conclusions
Unlike other populations, the authors found no correlation 
between abnormal delta SBP and clinical data plus 
left ventricular function in heart recipients at late post-
transplantation course. A significant number of these 
patients progress to attenuated delta SBP during ET. The 
pathophysiology of this behavior remains unknown. This 
phenomenon is probably multifactorial in origin, reflecting a 
distinctive characteristic of transplanted patients.
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